Why is Teva Pharmaceutical Industries Limited (TEVA) up 26.30% from the day 1 this year?

Let’s start up with the current stock price of Teva Pharmaceutical Industries Limited (TEVA), which is $11.38 to be very precise. The Stock rose vividly during the last session to $11.45 after opening rate of $10.70 while the lowest price it went was recorded $10.645 before closing at $10.79.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Recently in News on January 8, 2021, Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021. Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2020 financial results, as well as on its financial guidance for 2021, on Wednesday, February 10, 2021 at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET. You can read further details here

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .


Teva Pharmaceutical Industries Limited had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $11.47 on 01/06/21, with the lowest value was $9.71 for the same time period, recorded on 01/04/21.

Teva Pharmaceutical Industries Limited (TEVA) full year performance was 26.30%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Teva Pharmaceutical Industries Limited shares are logging -17.30% during the 52-week period from high price, and 82.08% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $6.25 and $13.76.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 10363667 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Teva Pharmaceutical Industries Limited (TEVA) recorded performance in the market was 17.93%, having the revenues showcasing 15.77% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 12.86B, as it employees total of 40039 workers.

The Analysts eye on Teva Pharmaceutical Industries Limited (TEVA)

During the last month, 4 analysts gave the Teva Pharmaceutical Industries Limited a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 15 analysts were recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 9.56, with a change in the price was noted +0.90. In a similar fashion, Teva Pharmaceutical Industries Limited posted a movement of +8.59% for the period of last 100 days, recording 8,453,358 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TEVA is recording 2.67 at the time of this writing. In addition, long term Debt to Equity ratio is set at 2.45.

Technical rundown of Teva Pharmaceutical Industries Limited (TEVA)

Raw Stochastic average of Teva Pharmaceutical Industries Limited in the period of last 50 days is set at 97.03%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 95.59%. In the last 20 days, the company’s Stochastic %K was 80.88% and its Stochastic %D was recorded 80.07%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Considering, the past performance of Teva Pharmaceutical Industries Limited, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 17.93%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -1.64%, alongside a boost of 26.30% for the period of the last 12 months. The shares increased approximately by 10.06% in the 7-day charts and went up by 6.85% in the period of the last 30 days. Common stock shares were driven by 15.77% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free


Please enter your comment!
Please enter your name here